|
14 Dec 2018 |
Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO® (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
|
|
14 Dec 2018 |
Astellas Acquires Potenza Therapeutics
|
|
14 Dec 2018 |
deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples
|
|
14 Dec 2018 |
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET™ Immunotherapy Drug Candidates
|
|
14 Dec 2018 |
Ridgeback Biotherapeutics LP announces licensing of mAb114, an experimental Ebola treatment, from the National Institute of Allergy and Infectious Diseases
|
|
14 Dec 2018 |
AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals
|
|
14 Dec 2018 |
Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School
|
|
14 Dec 2018 |
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
|
|
14 Dec 2018 |
Lilly to Acquire Pre-Clinical Pain Program from Hydra Biosciences
|
|
13 Dec 2018 |
Merck and Instituto Butantan Announce Collaboration Agreement to Develop Vaccines to Protect Against Dengue Infections
|
|
12 Dec 2018 |
BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD
|
|
12 Dec 2018 |
AC Immune and Lilly Announce License and Collaboration Agreement
|
|
12 Dec 2018 |
SHIONOGI and Ube Industries Entered into Strategic Research Collaboration for Novel Anti-RS Virus Drug Candidates
|
|
12 Dec 2018 |
Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever
|
|
12 Dec 2018 |
GARDP, Eisai and Takeda announce partnership in the search for new antibiotics
|
|
11 Dec 2018 |
Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses
|
|
11 Dec 2018 |
Avacta and LG Chem Life Sciences Agree Multi-Target Affimer Therapeutics Development Alliance
|
|
11 Dec 2018 |
HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
|
|
11 Dec 2018 |
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million
|
|
06 Dec 2018 |
XyloCor Therapeutics Raises $17 Million in Series A Financing to Advance Gene Therapy Portfolio in Cardiovascular Disease
|
|
06 Dec 2018 |
Casma Therapeutics Licenses Technology to Advance Autophagy-Based Drug Discovery
|
|
06 Dec 2018 |
4D Molecular Therapeutics Announces Collaboration to Advance Gene Therapies for Retinal Diseases with Oregon Health & Science University’s Casey Eye Institute and Oregon National Primate Research Center
|
|
06 Dec 2018 |
Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional Stem Cell Population
|
|
06 Dec 2018 |
Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data
|
|
05 Dec 2018 |
Icagen enters into Collaboration to Develop and Commercialize Therapy for Neurological Diseases
|
